Talk:Oncogenic osteomalacia
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||
|
The contents of the Phosphaturic mesenchymal tumor page were merged into Oncogenic osteomalacia. For the contribution history and old versions of the redirected page, please see its history; for the discussion at that location, see its talk page. (14 May 2017) |
Merge Phosphaturic mesenchymal tumor to here?[edit]
- yes as nom Wiki CRUK John (talk) 13:11, 11 June 2014 (UTC)
Done Klbrain (talk) 21:52, 14 May 2017 (UTC)
Add new treatment?[edit]
I'm too new to add this myself, but could an additional treatment paragraph be added, along the lines of: On June 18, 2020, the U.S. FDA approved a new treatment, Crysvita (burosumab-twza), for tumor-induced osteomalacia. https://www.fda.gov/news-events/press-announcements/fda-approves-first-therapy-rare-disease-causes-low-phosphate-blood-levels-bone-softening
Here's the Wikipedia page for Crysvita/burosumab: https://en.wikipedia.org/wiki/Burosumab AuthorGinJones (talk) 23:12, 19 October 2020 (UTC)